Peter Flanagan
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Biochemistry top 10%
- Blood transfusion and management
Papers in
- Hematology 11
- Blood groups and transfusion 6
- Platelet Disorders and Treatments 4
- Epidemiology 10
- Hepatitis B Virus Studies 7
- Co-authors
- Richard Charlewood (4 shared papers)Mary J. Berry (2 shared papers)T. R. O. Beringer (1 shared paper)J. A. J. Barbara (1 shared paper)Vladimír Šubr (1 shared paper)Aymen Al‐Shamkhani (1 shared paper)J Cassidy (1 shared paper)Ruth Duncan (1 shared paper)
- Journals
- Vox Sanguinis (6 papers)Transfusion (3 papers)Biologicals (1 paper)Journal of Hepatology (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United KingdomNew ZealandNigeria
In The Last Decade
Peter Flanagan
36 papers receiving 297 citations
Peers
Comparison fields: 5 of 68
- Hepatology 69
- Biochemistry 47
- Management of Technology and Innovation 51
- Hematology 56
- Genetics 30
Countries citing papers authored by Peter Flanagan
This map shows the geographic impact of Peter Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Flanagan more than expected).
Fields of papers citing papers by Peter Flanagan
This network shows the impact of papers produced by Peter Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Flanagan. The network helps show where Peter Flanagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Flanagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 32 | |
| 2 | 2004 | 31 | |
| 3 | 2012 | 28 | |
| 4 | 2019 | 27 | |
| 5 | Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors. | 2018 | 18 |
| 6 | 1988 | 18 | |
| 7 | 2013 | 15 | |
| 8 | 1995 | 15 | |
| 9 | Acute medical bed usage by nursing home residents. | 1999 | 14 |
| 10 | 2016 | 14 | |
| 11 | 1995 | 12 | |
| 12 | 1999 | 12 | |
| 13 | 1998 | 12 | |
| 14 | 2011 | 8 | |
| 15 | 2017 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2019 | 5 | |
| 18 | 2012 | 4 | |
| 19 | 1993 | 4 | |
| 20 | 1989 | 4 |
About Peter Flanagan
Peter Flanagan is a scholar working on Hematology, Epidemiology, Management of Technology and Innovation, Biochemistry and Hepatology, having authored 37 papers that have together received 319 indexed citations. Recurring topics across this work include Blood donation and transfusion practices (10 papers), Blood transfusion and management (8 papers), Hepatitis B Virus Studies (7 papers), Blood groups and transfusion (6 papers), Hepatitis C virus research (5 papers), Organ Donation and Transplantation (5 papers), Platelet Disorders and Treatments (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). The work is most often cited by research in Hepatology (69 citations), Biochemistry (47 citations), Management of Technology and Innovation (51 citations), Hematology (56 citations) and Genetics (30 citations). Peter Flanagan has collaborated with scholars based in United Kingdom, New Zealand and Nigeria. Frequent co-authors include Richard Charlewood, Mary J. Berry, T. R. O. Beringer, J. A. J. Barbara, Vladimír Šubr, Aymen Al‐Shamkhani, J Cassidy, Ruth Duncan, Leonard W. Seymour and Karel Ulbrich. Their work appears in journals such as Vox Sanguinis, Transfusion, Biologicals, Journal of Hepatology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.